Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Standard BioTools Inc. will present at the 43rd Annual J.P. Morgan Healthcare Conference, highlighting its role in advancing biomedical research and technologies [1][2]. Company Overview - Standard BioTools Inc. (NASDAQ: LAB), formerly known as Fluidigm Corporation, is a leading provider of next-generation technologies aimed at accelerating the development of medicines [3]. - The company offers proprietary technologies such as SomaScan, mass cytometry, and microfluidics, which provide reliable insights into health and disease [3]. - Standard BioTools collaborates with various sectors, including academic, government, pharmaceutical, and biotechnology, focusing on critical areas in translational and clinical research like oncology and immunology [3]. Event Details - The corporate presentation by Dr. Michael Egholm is scheduled for January 16, 2024, at 9:45 a.m. PT, with a live audio webcast available for investors [2]. - A recording of the presentation will be archived on the company's Investor Relations page [2].